Nirmala Sitharaman Defends GST On Covid Drugs, Equipment
Finance Minister Nirmala Sitharaman has defended the government's decision to tax Covid-19 related drugs and equipment. This, after West Bengal Chief Minister Mamata Banerjee wrote to the Prime Minister seeking tax exemption on a host of medicines and equipment being used in the treatment of the virus.
“...I would request that these items may be exempted from GST/customs duty and other such duties and taxes, to help remove supply constraints of the above mentioned life saving drugs and equipment and contribute towards effective management of Covid pandemic,” Banerjee wrote. Items listed out by her included oxygen cylinders, concentrators, Covid-19 drugs, among others.
Sitharaman responded on her twitter account, saying that the government has already reduced taxes on a number of items.
1/ Hon. CM of West Bengal @MamataOfficial has written to the Hon @PMOIndia seeking exemption from GST/Customs duty and other duties and taxes on some items and COVID related drugs.
May 9, 2021
My response is given in the following 15 tweets.@ANI @PIB_India @PIBKolkata pic.twitter.com/YmcZVuL7XO“With effect from May 3, 2021, full exemption from all duties has been provided to Remdesivir injections, Remdesivir API, and for a chemical for the manufacture of this drug,” Sitharaman said. “Also to Medical Oxygen, equipment used for the manufacture, storage and transportation of oxygen, equipment used for providing oxygen therapy to Covid patients such as Oxygen Concentrators, Ventilators, Non-invasive oxygen masks etc.”
Sitharaman went on to argue that part of the revenue collected via GST goes to the states.
“GST at rates varying from 5% (on vaccines), 12% (Covid drugs, oxygen concentrators) is applicable to domestic supplies and commercial import of these items,” she said. “If Integrated GST of Rs 100 is collected on an item, Rs 50 accrues to the Centre and the States each as Central GST and State GST respectively. Further 41% of the CGST revenue is devolved to States. So out of a collection of Rs 100, as much as Rs 70.50 is the States' share.”
Further, Sitharaman argued that if full exemption from GST were given, domestic producers would not be able to claim input tax credit.
“If full exemption from GST were given, the domestic producers of these items would be unable to offset taxes paid on their inputs and input services and would pass these on to the end consumers by increasing their price,” she said.
-
Signature Play: The Classic Cocktail Is Dead. Or Is It?
Classic cocktails are disappearing from India's cocktail menus. But they're still being ordered, taught to bartenders and borrowed from. So, who's really having the last drink?
-
A New Samvat Wishlist: Inclusive Prosperity And Human Development
India has strengthened its economic foundations through infrastructure, digital access and enterprise. Its next growth chapter must deepen productivity, create better livelihoods and widen participation in prosperity.
-
Love, Sex Aur Dhokha: The Audacious Plot To Spy On Jensen Huang
A Taipei dinner, a Singapore chip buyer and a suspected Chinese asset: inside the alleged spy operation that got close to NVIDIA's Jensen Huang.
-
Ten Things I Learnt This Samvat
Patience can be a trap. Cheap stocks can stay cheap. Leverage can wipe you out. What did Samvat 2082 teach us? Niraj Shah writes on 10 lessons from the year gone by.
-
Talking Points This Week: Tech Nerves, FII Buying, And A Faraway Banking Shock
The global markets are not shining this Diwali. The exception in the large markets is, India.
-
Midterm Rally Lasted A Day. The Hard Reality Of A Divided US May Last Two Years | Opinion
Between a contested AI boom, a debt ceiling that arrives in 2027 and a president with every incentive to act alone, the next two years may prove more volatile than the first day's rally suggests.
-
Blue Wave Will Derail the AI Trade but Won't Dismantle the AI Era | Unhedged Position
The Democrats' sweep of the US Congress will see politics collide with economic forces both over the long and short term.
-
It's Time To Take The GST Council's Bet On Trust Global
Payment records can prove India's services exports, and clear, proportionate rules can bring foreign digital sellers into the tax net.
-
Opinion | India at 38: From Innovation Overperformer to Innovation Powerhouse
India now has 453 VC-backed deep science startups, 18 of them late-stage, after 117 percent growth since 2020. Laurus Labs, at USD 9.3 billion, is the most valuable deep science company in any middle-income economy outside China.
